Table of Contents

company-logo

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Axsome Therapeutics Dividend Announcement

• Axsome Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Axsome Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Axsome Therapeutics Dividend History

Axsome Therapeutics Dividend Yield

Axsome Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Axsome Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Axsome Therapeutics Financial Ratios

P/E ratio-14.03
PEG ratio-0.95
P/B ratio42.08
ROE-174.48%
Payout ratio0.00%
Current ratio2.48
Quick ratio2.40
Cash Ratio1.69

Axsome Therapeutics Dividend FAQ

Does Axsome Therapeutics stock pay dividends?
Axsome Therapeutics does not currently pay dividends to its shareholders.
Has Axsome Therapeutics ever paid a dividend?
No, Axsome Therapeutics has no a history of paying dividends to its shareholders. Axsome Therapeutics is not known for its dividend payments.
Why doesn't Axsome Therapeutics pay dividends?
There are several potential reasons why Axsome Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Axsome Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Axsome Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Axsome Therapeutics a dividend aristocrat?
Axsome Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Axsome Therapeutics a dividend king?
Axsome Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Axsome Therapeutics a dividend stock?
No, Axsome Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Axsome Therapeutics stocks?
To buy Axsome Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Axsome Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.